What should you know about occult neuroblastoma?

Occult neuroblastoma refers to neuroblastoma found through testing when the original tumour is not readily visible or located. The term describes how the disease was discovered, not a separate type of cancer. Doctors combine examination, laboratory findings, imaging and tissue information to understand where disease is present and how it is behaving.

Neuroblastoma begins in immature nerve cells, often in tissues near the adrenal glands or along the spine. In an occult presentation, a scan or biopsy may show neuroblastoma while the primary site remains difficult to find. Nearby lymph nodes, bone or other areas may be assessed as part of staging. A pathology team may examine tumour cells and use specialised tests to help confirm the diagnosis.

The outlook and treatment plan depend on findings such as the child’s age, the areas involved, tumour biology and response to treatment. Those details cannot be inferred from the word occult alone.

Arrange care with a paediatric oncology team. Bring scan reports, pathology results, medication details and a record of symptoms. The team may recommend further imaging, blood or urine testing, bone marrow assessment, or review of stored tissue. Treatment can involve more than one approach, such as chemotherapy, an operation to remove tumour when feasible, or targeted radioisotope therapy. The choice is tailored to the child’s findings.

Contact the oncology team promptly for a new severe pain, repeated vomiting, marked weakness, difficulty walking, unusual bruising or bleeding, fever, breathing difficulty, or a child who is unusually sleepy or hard to wake. These signs can have several causes, but a child receiving cancer evaluation or treatment may need same-day assessment. Follow the team’s after-hours instructions rather than waiting for a routine appointment.

Ask where neuroblastoma has been found, which tests are still needed to search for a primary site, what the pathology shows, and how staging affects the plan. You can also ask which treatment is being considered first, how response will be monitored, which symptoms require an urgent call, and whether a second pathology review would be useful.